These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547 [TBL] [Abstract][Full Text] [Related]
3. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Pierangeli SS; Harris EN Lupus; 2003; 12(7):539-45. PubMed ID: 12892395 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway. Yasuda S; Bohgaki M; Atsumi T; Koike T Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497 [TBL] [Abstract][Full Text] [Related]
5. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Vega-Ostertag M; Casper K; Swerlick R; Ferrara D; Harris EN; Pierangeli SS Arthritis Rheum; 2005 May; 52(5):1545-54. PubMed ID: 15880836 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome. Cuadrado MJ; Buendía P; Velasco F; Aguirre MA; Barbarroja N; Torres LA; Khamashta M; López-Pedrera C J Thromb Haemost; 2006 Nov; 4(11):2461-9. PubMed ID: 16968331 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndrome. Amengual O; Atsumi T; Koike T Curr Vasc Pharmacol; 2011 Sep; 9(5):606-18. PubMed ID: 21692741 [TBL] [Abstract][Full Text] [Related]
8. Tissue factor in the antiphospholipid syndrome. Kinev AV; Roubey RA Lupus; 2008 Oct; 17(10):952-8. PubMed ID: 18827061 [TBL] [Abstract][Full Text] [Related]
9. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Pierangeli SS; Vega-Ostertag M; Harris EN Thromb Res; 2004; 114(5-6):467-76. PubMed ID: 15507280 [TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future. Mehdi AA; Uthman I; Khamashta M Eur J Clin Invest; 2010 May; 40(5):451-64. PubMed ID: 20345380 [TBL] [Abstract][Full Text] [Related]
11. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies. Bohgaki M; Atsumi T; Yamashita Y; Yasuda S; Sakai Y; Furusaki A; Bohgaki T; Amengual O; Amasaki Y; Koike T Int Immunol; 2004 Nov; 16(11):1633-41. PubMed ID: 15466912 [TBL] [Abstract][Full Text] [Related]
12. In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies. Montiel-Manzano G; Romay-Penabad Z; Papalardo de Martínez E; Meillon-García LA; García-Latorre E; Reyes-Maldonado E; Pierangeli SS Ann N Y Acad Sci; 2007 Jun; 1108():540-53. PubMed ID: 17894019 [TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid syndrome: an update. Merashli M; Noureldine MH; Uthman I; Khamashta M Eur J Clin Invest; 2015 Jun; 45(6):653-62. PubMed ID: 25851448 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482 [TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4. Laplante P; Fuentes R; Salem D; Subang R; Gillis MA; Hachem A; Farhat N; Qureshi ST; Fletcher CA; Roubey RA; Merhi Y; Thorin É; Levine JS; Mackman N; Rauch J Lupus; 2016 Feb; 25(2):162-76. PubMed ID: 26391610 [TBL] [Abstract][Full Text] [Related]
16. Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome. López-Pedrera C; Ruiz-Limón P; Aguirre MÁ; Barbarroja N; Pérez-Sánchez C; Buendía P; Rodriguez-García IC; Rodriguez-Ariza A; Collantes-Estevez E; Velasco F; Khasmahta M; Cuadrado MJ Ann Rheum Dis; 2011 Apr; 70(4):675-82. PubMed ID: 21173016 [TBL] [Abstract][Full Text] [Related]
17. Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody. Oku K; Amengual O; Zigon P; Horita T; Yasuda S; Atsumi T Rheumatology (Oxford); 2013 Oct; 52(10):1775-84. PubMed ID: 23878313 [TBL] [Abstract][Full Text] [Related]
18. The involvement of CD36 in monocyte activation by antiphospholipid antibodies. Kato M; Atsumi T; Oku K; Amengual O; Nakagawa H; Fujieda Y; Otomo K; Horita T; Yasuda S; Koike T Lupus; 2013 Jul; 22(8):761-71. PubMed ID: 23817509 [TBL] [Abstract][Full Text] [Related]
19. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Boles J; Mackman N Lupus; 2010 Apr; 19(4):370-8. PubMed ID: 20353972 [TBL] [Abstract][Full Text] [Related]
20. Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome. Girardi G Clin Rev Allergy Immunol; 2010 Dec; 39(3):160-5. PubMed ID: 19921475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]